Smart for Life (SMFL) Competitors $0.0080 0.00 (0.00%) As of 02/21/2025 09:55 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SMFL vs. UPC, SRNE, TCBP, NEXI, HSTO, NAVB, VAXX, SCPS, EVLO, and CMRAShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Universe Pharmaceuticals (UPC), Sorrento Therapeutics (SRNE), TC Biopharm (TCBP), NexImmune (NEXI), Histogen (HSTO), Navidea Biopharmaceuticals (NAVB), Vaxxinity (VAXX), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), and Comera Life Sciences (CMRA). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Universe Pharmaceuticals Sorrento Therapeutics TC Biopharm NexImmune Histogen Navidea Biopharmaceuticals Vaxxinity Scopus BioPharma Evelo Biosciences Comera Life Sciences Smart for Life (NASDAQ:SMFL) and Universe Pharmaceuticals (NYSE:UPC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, community ranking, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment. Does the media favor SMFL or UPC? In the previous week, Smart for Life's average media sentiment score of 0.00 equaled Universe Pharmaceuticals'average media sentiment score. Company Overall Sentiment Smart for Life Neutral Universe Pharmaceuticals Neutral Does the MarketBeat Community prefer SMFL or UPC? Smart for Life received 1 more outperform votes than Universe Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformSmart for LifeOutperform Votes1100.00% Underperform VotesNo VotesUniverse PharmaceuticalsN/AN/A Which has more risk and volatility, SMFL or UPC? Smart for Life has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. Comparatively, Universe Pharmaceuticals has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Do institutionals and insiders hold more shares of SMFL or UPC? 28.4% of Smart for Life shares are held by institutional investors. Comparatively, 0.2% of Universe Pharmaceuticals shares are held by institutional investors. 31.7% of Smart for Life shares are held by company insiders. Comparatively, 57.4% of Universe Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has higher earnings & valuation, SMFL or UPC? Universe Pharmaceuticals has higher revenue and earnings than Smart for Life. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$8.23M0.01-$22.68MN/AN/AUniverse Pharmaceuticals$32.31M0.01-$6.16MN/AN/A Is SMFL or UPC more profitable? Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A Universe Pharmaceuticals N/A N/A N/A SummaryUniverse Pharmaceuticals beats Smart for Life on 5 of the 7 factors compared between the two stocks. Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$60,000.00$1.16B$5.84B$9.14BDividend YieldN/AN/A4.75%3.85%P/E RatioN/A35.7826.0419.11Price / Sales0.015.72447.4676.36Price / CashN/A10.4038.0134.83Price / Book0.001.927.644.62Net Income-$22.68M-$53.22M$3.18B$245.85M7 Day PerformanceN/A-5.53%-2.00%-2.61%1 Month PerformanceN/A-1.92%-0.44%-2.14%1 Year PerformanceN/A-13.79%16.44%12.98% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.01flatN/A-99.9%$60,000.00$8.23M0.00110UPCUniverse PharmaceuticalsN/A$0.17-0.6%N/A-99.2%$280,000.00$32.31M0.00220Gap DownSRNESorrento TherapeuticsN/A$0.00-84.2%N/A-98.1%$220,000.00$62.84M0.00800Analyst ForecastGap DownTCBPTC Biopharm2.0244 of 5 stars$2.44-0.8%$48.00+1,867.2%-98.6%$150,000.00$4.76M0.0080Gap DownNEXINexImmuneN/A$0.10-9.9%N/AN/A$139,000.00N/A-0.016Gap DownHSTOHistogenN/A$0.03-5.9%N/A-93.3%$115,000.00$19,000.00-0.0120Gap DownHigh Trading VolumeNAVBNavidea BiopharmaceuticalsN/A$0.00+16.7%N/A-98.3%$70,000.00$8,126.000.0010Analyst ForecastGap UpVAXXVaxxinityN/A$0.00flatN/A-99.3%$30,000.00N/A0.0090High Trading VolumeSCPSScopus BioPharmaN/A$0.00flatN/A-91.7%$13,000.00N/A0.009EVLOEvelo BiosciencesN/A$0.00flatN/A-95.3%$9,000.00N/A0.00120Options VolumeNews CoverageCMRAComera Life SciencesN/A$0.00flatN/A-99.4%$6,000.00$630,000.000.002High Trading Volume Related Companies and Tools Related Companies Universe Pharmaceuticals Competitors Sorrento Therapeutics Competitors TC Biopharm Competitors NexImmune Competitors Histogen Competitors Navidea Biopharmaceuticals Competitors Vaxxinity Competitors Scopus BioPharma Competitors Evelo Biosciences Competitors Comera Life Sciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SMFL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.